NCT01923740View on ClinicalTrials.gov

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT)

NACompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

March 7, 2019

Conditions
Coronary Artery DiseaseCoronary Artery StenosisCoronary DiseaseCoronary Stenosis
Interventions
DEVICE

XIENCE V EECSS

Subjects receiving XIENCE V

DEVICE

Absorb BVS System

Subjects receiving Absorb BVS System

Trial Locations (1)

95054

Abbott Vascular, Santa Clara

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01923740 - A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) | Biotech Hunter | Biotech Hunter